Deerland Probiotics & Enzymes

Carlsquare advised the shareholders of Bifodan in relation to a sale and partial reinvestment into Deerland Probiotics & Enzymes, a platform investment of US-based Roundtable Healthcare Partners.

Bifodan

sold to

Deerland Probiotics & Enzymes

Member
Carlsquare GmbH

Sector
Healthcare / Pharmaceuticals / MedTech / Lifescience

Date completed
11.11.2019

Target company
Bifodan

Target country
Denmark

Acquirer company
Deerland Probiotics & Enzymes

Acquirer country
United States

Get in touch and let's talk about how we could help your business.

Get Started